Search - tctmd.com

Displaying 1 - 20 of 377

Sort: Relevancy | Date

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Daily News

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

Michael O'Riordan

December 23, 2025

News Daily News

Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges

Caitlin E. Cox

November 21, 2025

News Conference News AHA 2025

Stress CMR Facilitates Diagnosis, Targeted Care in ANOCA: CorCMR

Caitlin E. Cox

November 14, 2025

News Conference News AHA 2025

POLY-HF: Polypill Pays Dividends in Patients With HFrEF

Todd Neale

November 14, 2025

Presentation TCT 2025

TCT 831: Role of Intraprocedural Hemodynamics to Predict Clinical Outcomes After Mitral Transcatheter Edge-to-Edge Repair for Secondary MR

Presenter: Tyler Edward Klee

October 28, 2025

News Conference News TCT 2025

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

Todd Neale

October 27, 2025

News Conference News TCT 2025

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

Yael L. Maxwell

October 27, 2025

Presentation TCT 2025

Expansion of Indication in M-TEER: Is Moderate Mitral Regurgitation the New Target?

Presenter: Stephan Baldus

October 27, 2025

Presentation TCT 2025

Imaging Planning in Secondary MR: Anatomical Predictors of M-TEER Success

Presenter: Rebecca T. Hahn

October 27, 2025

Presentation TCT 2025

Secondary MR: Phenotypic Classification and Implications for Therapy

Presenter: Linda D. Gillam

October 27, 2025

Presentation TCT 2025

M-TEER in Secondary MR: What the Clinical Evidence Shows

Presenter: Gregg W. Stone

October 27, 2025

News Conference News ESC 2025

ESC/EACTS Release New Valvular Heart Disease Guidelines

Yael L. Maxwell

September 03, 2025

News Daily News

AF Touted as ‘Bad Player’ in Patients Undergoing Mitral TEER

L.A. McKeown

July 30, 2025

News Conference News NY Valves 2025

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Yael L. Maxwell

July 03, 2025

News Conference News NY Valves 2025

Global Burden of Degenerative Mitral Valve Disease Continues to Rise

Todd Neale

June 30, 2025

Presentation NY Valves 2025

Posterior Leaflet Restoration to Reduce Secondary MR Using the MRace System (EXPLORE MR): Early Feasibility Experience (Polares)

Presenter: Fabio Sandoli de Brito

June 26, 2025

Presentation NY Valves 2025

Early Feasibility Experience of Posterior Leaflet Restoration to Reduce Secondary MR Using the MRace Implant (EXPLORE MR)

Presenter: Fabio Sandoli de Brito

June 25, 2025

Presentation NY Valves 2025

Mitral TEER in Symptomatic FMR: Emerging Data and Futuristic Trends

Presenter: Gregg W. Stone

June 25, 2025

Presentation NY Valves 2025

Optimizing Mitral TEER in FMR: Technical and Device Strategies

Presenter: Jörg Hausleiter

June 25, 2025

Advertisement

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges

Stress CMR Facilitates Diagnosis, Targeted Care in ANOCA: CorCMR

POLY-HF: Polypill Pays Dividends in Patients With HFrEF

TCT 831: Role of Intraprocedural Hemodynamics to Predict Clinical Outcomes After Mitral Transcatheter Edge-to-Edge Repair for Secondary MR

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

Expansion of Indication in M-TEER: Is Moderate Mitral Regurgitation the New Target?

Imaging Planning in Secondary MR: Anatomical Predictors of M-TEER Success

Secondary MR: Phenotypic Classification and Implications for Therapy

M-TEER in Secondary MR: What the Clinical Evidence Shows

ESC/EACTS Release New Valvular Heart Disease Guidelines

AF Touted as ‘Bad Player’ in Patients Undergoing Mitral TEER

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Global Burden of Degenerative Mitral Valve Disease Continues to Rise

Posterior Leaflet Restoration to Reduce Secondary MR Using the MRace System (EXPLORE MR): Early Feasibility Experience (Polares)

Early Feasibility Experience of Posterior Leaflet Restoration to Reduce Secondary MR Using the MRace Implant (EXPLORE MR)

Mitral TEER in Symptomatic FMR: Emerging Data and Futuristic Trends

Optimizing Mitral TEER in FMR: Technical and Device Strategies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content